Science Explorer Back to mapMap
Discussion
Topic · Neurology

Autoimmune Neurological Disorders and Treatments

Autoimmune Neurological Disorders and Treatments is a research topic within Neurology. Science Explorer counts 13k research works in it since 1950. 10.1% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on autoimmune encephalitis, particularly the clinical characteristics, diagnostic criteria, and management of conditions such as anti-NMDA receptor encephalitis, paraneoplastic syndromes, and limbic encephalitis. It explores the role of autoantibodies, immunotherapy, and the neurological manifestations of autoimmune diseases. Additionally, it discusses specific conditions like Hashimoto encephalopathy and cognitive impairment associated with these disorders.

  • Anti-NMDA Receptor Encephalitis
  • Paraneoplastic Syndromes
  • Autoantibodies
  • Neurological Disorders
  • Immunotherapy
  • Limbic Encephalitis
  • Diagnostic Criteria
  • Neuronal Autoantigens
  • Hashimoto Encephalopathy
  • Cognitive Impairment
Research works
13k
fractional, since 1950
In the world top 10%
1.3k
per year above
Top-10% rate
10.1%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+27%
the tick is no change
Largest producer
United States
31% of the 10 largest, 2022-now
Autoimmune Neurological Disorders and Treatments

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Autoimmune Neurological Disorders and Treatments research?

By volume, the United States and China publish the most (902 and 643 works in 2022-now).

By volume, 2022-now

  1. 1 United States 902 works
  2. 2 China 643 works
  3. 3 Japan 263 works
  4. 4 India 246 works
  5. 5 Germany 192 works
  6. 6 United Kingdom 167 works
  7. 7 Italy 153 works
  8. 8 France 146 works
  9. 9 Spain 120 works
  10. 10 Türkiye 86 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 30.9%China: 22.0%Japan: 9.0%India: 8.4%6 others listed: 29.6%31%largest
United States902 · 30.9%China643 · 22.0%Japan263 · 9.0%India246 · 8.4%6 others listed864 · 29.6%

Shares of the rows listed above, not of the whole node.

Which institutions lead Autoimmune Neurological Disorders and Treatments research?

By volume in 2022-now, Mayo Clinic publishes the most Autoimmune Neurological Disorders and Treatments research, followed by Capital Medical University and Harvard University.

Who are the leading researchers in Autoimmune Neurological Disorders and Treatments?

The most-cited researchers publishing on Autoimmune Neurological Disorders and Treatments include Gregory Y.H. Lip, Karl John Friston and John Q. Trojanowski.

  1. 1 Gregory Y.H. Lip United Kingdom 311k citations
  2. 2 Karl John Friston United Kingdom 310k citations
  3. 3 John Q. Trojanowski United States 286k citations
  4. 4 Kaj Blennow Sweden 247k citations
  5. 5 John Hardy United Kingdom 243k citations
  6. 6 John C. Morris United States 241k citations
  7. 7 Dennis W. Dickson United States 237k citations
  8. 8 Matthew James Page Australia 235k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Autoimmune Neurological Disorders and Treatments?

The most cited paper in Autoimmune Neurological Disorders and Treatments is "A clinical approach to diagnosis of autoimmune encephalitis" (Francesc Graus et al., 2016), with 4,550 citations. Next come "Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies" (3,513) and "A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis" (3,258).

Most cited papers
#PaperReleasedCitations
1 A clinical approach to diagnosis of autoimmune encephalitis Francesc Graus et al. · The Lancet Neurology Open access 20 Feb 2016 4,550
2 Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies Josep O. Dalmau, Amy J. Gleichman, Ethan G. Hughes et al. · The Lancet Neurology Open access 15 Oct 2008 3,513
3 A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis Vanda A. Lennon, Dean M. Wingerchuk, Thomas J. Kryzer et al. · The Lancet Dec 2004 3,258
4 Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study Maarten J. Titulaer, Lindsey McCracken, Iñigo Gabilondo et al. · The Lancet Neurology Open access 2 Jan 2013 3,173
5 Paraneoplastic anti– N ‐methyl‐ D ‐aspartate receptor encephalitis associated with ovarian teratoma Josep O. Dalmau, Erdem Tüzün, Haiyan Wu et al. · Annals of Neurology Open access 2007 2,506
All 100 most cited papers, with filters and sorting

Where is Autoimmune Neurological Disorders and Treatments research done?

The largest centres of Autoimmune Neurological Disorders and Treatments research in 2022-now are Beijing (China), London (United Kingdom), Tokyo (Japan) and Paris (France). Among places with at least 20 works in it, it is an unusually large share of all research in Rochester, Scottsdale and Cleveland.

Largest cities, 2022-now

  1. 1 BeijingChina 95 works
  2. 2 LondonUnited Kingdom 64 works
  3. 3 TokyoJapan 64 works
  4. 4 ParisFrance 62 works
  5. 5 ShanghaiChina 44 works
  6. 6 GuangzhouChina 44 works
  7. 7 BarcelonaSpain 41 works
  8. 8 ChengduChina 40 works
  9. 9 SeoulSouth Korea 38 works
  10. 10 New YorkUnited States 35 works

Where it is the local speciality

  1. RochesterUS · 20.5 works13×
  2. ScottsdaleUS · 20.3 works11×
  3. ClevelandUS · 32.0 works5.8×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Autoimmune Neurological Disorders and Treatments than the world average.

See Autoimmune Neurological Disorders and Treatments on the map

Where is the best place to study Autoimmune Neurological Disorders and Treatments?

Among universities, judged by research, Johns Hopkins University, Erasmus University Rotterdam and Universitat de Barcelona score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 18.84%fractional works in this field (log) →share of work in the world top 10% →Erasmus University R…Johns Hopkins Univer…Universitat de Barce…The University of Sy…
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Citation excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Johns Hopkins UniversityUnited States 64.815.9%4.8×26 +47.1%
2Erasmus University RotterdamNetherlands 64.234.3%5.1×9 +4.4%
3Universitat de BarcelonaSpain 61.414.4%6.3×17 +48.4%
4The University of SydneyAustralia 59.912.6%5.0×21 +32.1%
5Capital Medical UniversityChina 59.46.0%9.9×37 +68.7%
6University of OxfordUnited Kingdom 58.623.5%3.4×16 -10.4%
7University College LondonUnited Kingdom 58.215.6%3.7×20 -2.2%
8Central South UniversityChina 56.118.1%3.1×21 +102.2%
9Monash UniversityAustralia 54.930.8%2.4×8 +154.7%
10Zhengzhou UniversityChina 54.817.2%5.2×22 +60.1%

Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Autoimmune Neurological Disorders and Treatments, country by country

Is Autoimmune Neurological Disorders and Treatments research growing?

Output in 2022-2025 was 27% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Autoimmune Neurological Disorders and Treatments.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Autoimmune Neurological Disorders and Treatments as a percentage of every work published that year, 0.014% in 2024.

still counting0.010%0.020%Autoimmune Neurological Disorders and Treatments0.018% in 202519801990200020102020

Fractional works of Autoimmune Neurological Disorders and Treatments over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Autoimmune Neurological Disorders and Treatments9.8% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Autoimmune Neurological Disorders and Treatments. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.